Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.

<h4>Background</h4>SEPN1, a selenoprotein involved in redox regulation and endoplasmic reticulum stress response, has an unclear role in cancer. This study aims to investigate the expression, prognostic significance, and tumor microenvironment (TME) relevance of SEPN1 across pan-cancer,...

Full description

Saved in:
Bibliographic Details
Main Authors: Zisong Wang, Danwen Wang, Xuanyu Wang, Yihang Xu, Yunhe Yuan, Yuxin Chen, Zhiqiang Li, Xiaoping Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0318501
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856757134327808
author Zisong Wang
Danwen Wang
Xuanyu Wang
Yihang Xu
Yunhe Yuan
Yuxin Chen
Zhiqiang Li
Xiaoping Liu
author_facet Zisong Wang
Danwen Wang
Xuanyu Wang
Yihang Xu
Yunhe Yuan
Yuxin Chen
Zhiqiang Li
Xiaoping Liu
author_sort Zisong Wang
collection DOAJ
description <h4>Background</h4>SEPN1, a selenoprotein involved in redox regulation and endoplasmic reticulum stress response, has an unclear role in cancer. This study aims to investigate the expression, prognostic significance, and tumor microenvironment (TME) relevance of SEPN1 across pan-cancer, with a particular focus on glioma.<h4>Methods</h4>We analyzed SEPN1 expression and prognosis using the TCGA pan-cancer cohort. SEPN1 in glioma was further examined using data from TCGA, CGGA, GEO, and ZN-GC cohorts, along with survival analysis, single-cell RNA sequencing analysis, and enrichment analysis. We developed an SEPN1-related risk score (SRS) based on SEPN1-related long non-coding RNAs and validated its prognostic value. Drug sensitivity data and connectivity map analysis identified potential anti-glioma drugs based on the SRS.<h4>Results</h4>We found that SEPN1 was significantly upregulated in glioma, associated with poor prognosis, functioned as an independent risk factor, and predominantly expressed in malignant glioma cells. Enrichment analysis indicated the involvement of SEPN1 in immune-related processes and signaling pathways. Suppressing SEPN1 in glioblastoma cells inhibited proliferation and induced G2/M arrest and apoptosis. The SRS demonstrated strong prognostic value and correlated with enhanced immune infiltration in the glioma TME. Potential anti-glioma drugs were identified based on the SRS.<h4>Conclusions</h4>SEPN1 emerges as a novel biomarker and therapeutic target in glioma, providing a basis for future development of targeted therapies.
format Article
id doaj-art-9702fd74b1844791a5a6fcd789158f00
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-9702fd74b1844791a5a6fcd789158f002025-02-12T05:31:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031850110.1371/journal.pone.0318501Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.Zisong WangDanwen WangXuanyu WangYihang XuYunhe YuanYuxin ChenZhiqiang LiXiaoping Liu<h4>Background</h4>SEPN1, a selenoprotein involved in redox regulation and endoplasmic reticulum stress response, has an unclear role in cancer. This study aims to investigate the expression, prognostic significance, and tumor microenvironment (TME) relevance of SEPN1 across pan-cancer, with a particular focus on glioma.<h4>Methods</h4>We analyzed SEPN1 expression and prognosis using the TCGA pan-cancer cohort. SEPN1 in glioma was further examined using data from TCGA, CGGA, GEO, and ZN-GC cohorts, along with survival analysis, single-cell RNA sequencing analysis, and enrichment analysis. We developed an SEPN1-related risk score (SRS) based on SEPN1-related long non-coding RNAs and validated its prognostic value. Drug sensitivity data and connectivity map analysis identified potential anti-glioma drugs based on the SRS.<h4>Results</h4>We found that SEPN1 was significantly upregulated in glioma, associated with poor prognosis, functioned as an independent risk factor, and predominantly expressed in malignant glioma cells. Enrichment analysis indicated the involvement of SEPN1 in immune-related processes and signaling pathways. Suppressing SEPN1 in glioblastoma cells inhibited proliferation and induced G2/M arrest and apoptosis. The SRS demonstrated strong prognostic value and correlated with enhanced immune infiltration in the glioma TME. Potential anti-glioma drugs were identified based on the SRS.<h4>Conclusions</h4>SEPN1 emerges as a novel biomarker and therapeutic target in glioma, providing a basis for future development of targeted therapies.https://doi.org/10.1371/journal.pone.0318501
spellingShingle Zisong Wang
Danwen Wang
Xuanyu Wang
Yihang Xu
Yunhe Yuan
Yuxin Chen
Zhiqiang Li
Xiaoping Liu
Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
PLoS ONE
title Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
title_full Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
title_fullStr Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
title_full_unstemmed Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
title_short Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
title_sort integrative analysis of sepn1 in glioma prognostic roles functional implications and potential therapeutic interventions
url https://doi.org/10.1371/journal.pone.0318501
work_keys_str_mv AT zisongwang integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT danwenwang integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT xuanyuwang integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT yihangxu integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT yunheyuan integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT yuxinchen integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT zhiqiangli integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions
AT xiaopingliu integrativeanalysisofsepn1ingliomaprognosticrolesfunctionalimplicationsandpotentialtherapeuticinterventions